Aerovate Price Fair Value from 2010 to 2024

AVTE Stock  USD 2.64  0.04  1.49%   
Aerovate Therapeutics' Price Fair Value is increasing over the years with slightly volatile fluctuation. Overall, Price Fair Value is expected to go to 5.72 this year. During the period from 2010 to 2024 Aerovate Therapeutics Price Fair Value annual values regression line had coefficient of variation of (70.72) and r-squared of  0.69. View All Fundamentals
 
Price Fair Value  
First Reported
2010-12-31
Previous Quarter
5.44392751
Current Value
5.72
Quarterly Volatility
73.22333966
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Aerovate Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Aerovate Therapeutics' main balance sheet or income statement drivers, such as Net Interest Income of 5.4 M, Depreciation And Amortization of 100.8 K or Interest Expense of 2.1 M, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 5.72. Aerovate financial statements analysis is a perfect complement when working with Aerovate Therapeutics Valuation or Volatility modules.
  
Check out the analysis of Aerovate Therapeutics Correlation against competitors.
For information on how to trade Aerovate Stock refer to our How to Trade Aerovate Stock guide.

Latest Aerovate Therapeutics' Price Fair Value Growth Pattern

Below is the plot of the Price Fair Value of Aerovate Therapeutics over the last few years. It is Aerovate Therapeutics' Price Fair Value historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Aerovate Therapeutics' overall financial position and show how it may be relating to other accounts over time.
Price Fair Value10 Years Trend
Slightly volatile
   Price Fair Value   
       Timeline  

Aerovate Price Fair Value Regression Statistics

Arithmetic Mean(103.54)
Coefficient Of Variation(70.72)
Mean Deviation65.92
Median(152.98)
Standard Deviation73.22
Sample Variance5,362
Range159
R-Value0.83
Mean Square Error1,793
R-Squared0.69
Significance0.0001
Slope13.60
Total Sum of Squares75,063

Aerovate Price Fair Value History

2024 5.72
2023 5.44
2022 5.66
2021 1.67
2020 -41.76

About Aerovate Therapeutics Financial Statements

Aerovate Therapeutics stakeholders use historical fundamental indicators, such as Aerovate Therapeutics' Price Fair Value, to determine how well the company is positioned to perform in the future. Although Aerovate Therapeutics investors may analyze each financial statement separately, they are all interrelated. For example, changes in Aerovate Therapeutics' assets and liabilities are reflected in the revenues and expenses on Aerovate Therapeutics' income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Aerovate Therapeutics. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Price Fair Value 5.44  5.72 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Aerovate Therapeutics is a strong investment it is important to analyze Aerovate Therapeutics' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Aerovate Therapeutics' future performance. For an informed investment choice regarding Aerovate Stock, refer to the following important reports:
Check out the analysis of Aerovate Therapeutics Correlation against competitors.
For information on how to trade Aerovate Stock refer to our How to Trade Aerovate Stock guide.
You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Aerovate Therapeutics. If investors know Aerovate will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Aerovate Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(2.99)
Return On Assets
(0.49)
Return On Equity
(0.82)
The market value of Aerovate Therapeutics is measured differently than its book value, which is the value of Aerovate that is recorded on the company's balance sheet. Investors also form their own opinion of Aerovate Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Aerovate Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Aerovate Therapeutics' market value can be influenced by many factors that don't directly affect Aerovate Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Aerovate Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Aerovate Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Aerovate Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.